S. Holden

发表

Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance

D. Pennell, L. Anderson, M. Westwood, 2004, British journal of haematology.

Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia ☆

D. Pennell, L. Anderson, J. M. Walker, 2003 .

Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia

D. Pennell, L. Anderson, J. M. Walker, 2002, The Lancet.

Cardiac iron deposition is not predicted by conventional markers of iron overload in homozygous beta-thalassaemia.

D. Pennell, D. Firmin, L. Anderson, 2000 .

A novel method of cardiac iron measurement using magnetic resonance T2*imaging in thalassemia: Validation and clinical application

D. Pennell, D. Firmin, L. Anderson, 2000 .

Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload.

D N Firmin, D J Pennell, D. Pennell, 2001, European heart journal.

Tissue Doppler echocardiography in patients with thalassaemia detects early myocardial dysfunction related to myocardial iron overload.

D. Pennell, L. Anderson, J. Deanfield, 2003, European heart journal.

Hepatic iron concentration combined with long‐term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major

A. Hoffbrand, B. Wonke, S. Holden, 2000, British journal of haematology.